Kazakhstan turns to AI for faster stroke detection
AI tools like RapidAI and local startup Cerebra help Kazakh doctors diagnose strokes quickly and save lives through early intervention
ASTANA, Kazakhstan (MNTV) — Kazakhstan is increasingly adopting artificial intelligence to improve early diagnosis and treatment of brain disorders, especially strokes, which claim thousands of lives each year and leave many more disabled.
According to a report by Silk Way TV, local hospitals are using tools like RapidAI, a global medical imaging platform that visualizes vascular brain damage in real time and instantly shares results with medical teams.
Alongside it, Kazakh doctors are piloting a domestic innovation—Cerebra, an AI-powered system that reads CT scans and identifies the type of stroke in just minutes, enabling life-saving decisions without delay.
“We’ve rolled out Cerebra in several major hospitals, including the 2nd city hospital in Astana and the 7th in Almaty,” said Yerzhan Adilbekov, Chair of the National Coordination Center for Emergency Medicine. “Initial results have been very promising.”
According to the center, around 40,000 cases of acute cerebrovascular accidents are recorded in Kazakhstan each year. Swift diagnosis and intervention can be the difference between recovery and long-term impairment or death.
Karashash Zhakibayeva, a recent stroke patient, shared her experience: “When I arrived, I couldn’t move one arm or leg. I had no idea this place even existed. But within a day, I was able to feed myself, walk, and even look out the window. I’m so thankful.”
Health authorities are also promoting public awareness. Doctors emphasize the FAST test—Face drooping, Arm weakness, Speech difficulty, and Time to act—as a simple tool to recognize stroke symptoms. If any of these signs appear, they say, the patient must reach a stroke center within 4.5 hours. There are currently 83 such centers operating nationwide.
As Kazakhstan’s health system embraces AI, officials hope these technologies will reduce the time between onset and treatment, boost survival rates, and improve long-term outcomes for stroke victims.